| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.6 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |